Lee Ainslie Merck & Co., Inc. Transaction History

Maverick Capital LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $547,183 - $595,467	-5,462 Reduced 39.43%	8,389 $914,000
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $859,529 - $954,541	8,349 Added 151.74%	13,851 $1.43 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $597,572 - $651,326	5,502 New	5,502 $634,000
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $56,573 - $72,535	-647 Reduced 24.7%	1,972 $218,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $221,384 - $248,700	2,619 New	2,619 $226,000
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $72,858 - $91,264	-1,008 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $320,552 - $352,527	-4,472 Reduced 81.61%	1,008 $76,000
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $1.89 Million - $2.09 Million	-26,865 Reduced 83.06%	5,480 $426,000
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $1.85 Million - $2.18 Million	-26,898 Reduced 45.4%	32,345 $2.49 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $2.63 Million - $2.92 Million	36,612 Added 161.78%	59,243 $4.85 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $96,158 - $108,996	-1,314 Reduced 5.49%	22,631 $1.88 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $1.67 Million - $1.9 Million	23,696 Added 9516.47%	23,945 $1.85 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $15,776 - $21,867	249 New	249 $19,000
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $1.16 Million - $1.31 Million	-14,928 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $1.14 Million - $1.24 Million	14,928 New	14,928 $1.26 Million

3,855

1.89B

15.5M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $223B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.